AbbVie (ABBV) Payables (2011 - 2026)
AbbVie's Payables was $34.43 billion in Q3 2026, down 8.0% from $37.41 billion a year earlier but up 3.4% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Payables at AbbVie came in at $37.23 billion, up 16.6% from FY2024.
- Payables has now increased for six consecutive years, with a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- In earlier years, Payables was $31.95 billion in FY2024 (+4.2%), $30.65 billion in FY2023 (+20.7%), $25.4 billion in FY2022 (+11.8%) and $22.71 billion in FY2021 (+12.5%).
- Quarterly Payables has moved between $22.56 billion (Q2 2022) and $37.8 billion (Q2 2025) over five years.
- Compared with a year earlier, Payables was higher in six of the last eight quarters, with growth averaging 7.5%.
- The best year-over-year quarter for Payables over five years was Q2 2025 (growth of 28.9%); the worst was Q2 2026 (a decline of 11.9%).
- Per Business Quant data, ABBV's Payables in the three quarters before Q3 2026 was $33.3 billion (Q2 2026), $33.77 billion (Q1 2026) and $37.23 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 472.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.43 Bn |
| Jun 30, 2026 | 33.30 Bn |
| Mar 31, 2026 | 33.77 Bn |
| Dec 31, 2025 | 37.23 Bn |
| Sep 30, 2025 | 37.41 Bn |
| Jun 30, 2025 | 37.80 Bn |
| Mar 31, 2025 | 32.63 Bn |
| Dec 31, 2024 | 31.95 Bn |
| Sep 30, 2024 | 30.49 Bn |
| Jun 30, 2024 | 29.33 Bn |
| Mar 31, 2024 | 31.33 Bn |
| Dec 31, 2023 | 30.65 Bn |
| Sep 30, 2023 | 29.66 Bn |
| Jun 30, 2023 | 27.04 Bn |
| Mar 31, 2023 | 24.79 Bn |
| Dec 31, 2022 | 25.40 Bn |
| Sep 30, 2022 | 23.52 Bn |
| Jun 30, 2022 | 22.56 Bn |
| Mar 31, 2022 | 22.58 Bn |
| Dec 31, 2021 | 22.71 Bn |
API Access
AbbVie Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();